The Minnesota Department of Health (MDH) has announced it has added irritable bowel syndrome (IBS) and obsessive-compulsive disorder (OCD) to the list of qualifying medical conditions for participation in Minnesota’s medical cannabis programme.
The state has confirmed that patients living with IBS or OCD can now enrol in the state’s medical cannabis program following approval for the conditions to qualify for the programme during last year’s MDH annual petition and public comment process.
Patients who have been certified by a participating health care practitioner as having either of these conditions will also be able to buy medical cannabis at a medical cannabis dispensary from 1 August, 2023.
READ MORE: Cannabis Data for Rescheduling Review Handed to Government
Minnesota Commissioner of Health Dr Brooke Cunningham stated: “As we continue to learn more about the benefits of medical cannabis, it’s important that we add this therapy option as a potential treatment to relieve conditions that can be debilitating.”
Minnesota’s medical cannabis program now has 19 qualifying medical conditions.
IBS and OCD were approved as qualifying conditions for the medical cannabis programme in light of clinical research showing the treatment can offer relief for IBS and OCD patients.
